Author:
Levy R.,Ruberg M.,Herrero M. T.,Villares J.,Javoy-Agid F.,Agid Y.,Hirsch E. C.
Abstract
Article abstract-We analyzed postmortem GABAergic neurons in the basal ganglia of three patients with progressive supranuclear palsy (PSP) and four matched controls by means of glutamic acid decarboxylase (Mr 67,000 (GAD67)) mRNA in situ hybridization. In PSP, we found a 50 to 60% decrease in the number of neurons expressing GAD67 mRNA in the caudate nucleus, ventral striatum, and the external and internal pallidum. The expression of GAD67 mRNA per neuron was reduced in the caudate nucleus and putamen (-43%), the ventral striatum (-55%), and the external and internal pallidum (-59% and -68%). Our data indicate that striatal and pallidal GABAergic neurotransmission is markedly reduced in PSP and we suggest that this alteration may account for the motor and cognitive symptoms observed in PSP. Furthermore, the destruction of the basal ganglia output systems may explain the lack of responsiveness to L-dopa therapy of PSP patients.NEUROLOGY 1995;45: 127-134
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference54 articles.
1. Agid Y, Javoy-Agid F, Ruberg M, et al. Progressive supranuclear palsy: anatomoclinical and biochemical considerations. In: Yahr MD, Bergman KJ, eds. Advances in neurology, vol. 45. New York: Raven Press, 1986:191-206.
2. Jellinger KA, Bancher C. Neuropathology, chapter 4. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy. New York: Oxford University Press, 1992:44-88.
3. Hauw J-J, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994; 44:2015-2019.
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献